The proinflammatory role of matrix metalloproteinase-2 in chronic obstructive pulmonary disease

被引:0
|
作者
Nishihama, K. [1 ]
D'Alessandro-Gabazza, C. N. [1 ]
Toda, M. [1 ]
Yasuma, T. [1 ]
Hinneh, J. [1 ]
Etsuko, H. [1 ]
Kentaro, F. [2 ]
Kobayashi, T. [2 ]
Gabazza, E. [2 ]
机构
[1] Mie Univ, Sch Med, Dept Immunol, Tsu, Mie, Japan
[2] Mie Univ, Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie, Japan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
305
引用
收藏
页码:383 / 383
页数:1
相关论文
共 50 条
  • [1] MATRIX METALLOPROTEINASE INHIBITORS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Antoniu, S. A.
    [J]. DRUGS OF THE FUTURE, 2012, 37 (07) : 523 - 529
  • [2] Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
    Zhang, Yongxiang
    Li, Yuechuan
    Ye, Zhen
    Ma, Hui
    [J]. MEDICAL SCIENCE MONITOR, 2020, 26 : e925278
  • [3] Matrix metalloproteinases and the potential therapeutic role for matrix metalloproteinase inhibitors in chronic obstructive pulmonary disease (COPD)
    Bottomley, KM
    Belvisi, MG
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 209 - 216
  • [4] Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease
    Kochetkova, E. A.
    Ugai, L. G.
    Maistrovskaya, Yu V.
    Burya, K. A.
    Nevzorova, V. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2012, 84 (08): : 37 - 40
  • [5] Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9
    Grzela, Katarzyna
    Litwiniuk, Malgorzata
    Zagorska, Wioletta
    Grzela, Tomasz
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (01) : 47 - 55
  • [6] Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9
    Katarzyna Grzela
    Malgorzata Litwiniuk
    Wioletta Zagorska
    Tomasz Grzela
    [J]. Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 47 - 55
  • [7] MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 ARE ASSOCIATED WITH HYPERTENSION TO THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH PRIMARY CHRONIC GLOMERULONEPHRITIS
    Dimas, G.
    Tegos, T.
    Spiroglou, S.
    Karamouzis, I.
    Kanellos, I.
    Savopoulos, C.
    Hatzitolios, A.
    Grekas, D.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E356 - E356
  • [8] MATRIX METALLOPROTEINASE-2,-9 IN CHILDREN WITH CHRONIC KIDNEY DISEASE AND DIABETES
    Stabouli, S.
    Maliachova, O.
    Printza, N.
    Chainoglou, A.
    Christoforidis, A.
    Taparkou, A.
    Dotis, J.
    Kotsis, V.
    Farmaki, E.
    Zafeiriou, D.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 : E224 - E224
  • [9] The Role of Matrix Metalloproteinase-2 in Vitiligo Treatment
    Celik, Heybet Ozkaya
    Yilmazer, Demet
    Atacan, Damla
    Eskioglu, Fatma
    Alper, Murat
    [J]. TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (04): : 216 - 219
  • [10] Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
    Inoue, Ryo
    Yasuma, Taro
    D'Alessandro, Valeria Fridman
    Toda, Masaaki
    Ito, Toshiyuki
    Tomaru, Atsushi
    D'Alessandro-Gabazza, Corina N. N.
    Tsuruga, Tatsuki
    Okano, Tomohito
    Takeshita, Atsuro
    Nishihama, Kota
    Fujimoto, Hajime
    Kobayashi, Tetsu
    Gabazza, Esteban C. C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)